Global Stem Cell Market Scrutinized by TriMark in Topical Research Report Published at MarketPublishers.com
28 Oct 2013 • by Natalie Aster
LONDON – In 2011, the global stem cell market was worth over USD 26.2 billion. In the same year, adult stem cells held the lion’s share of the overall market (around 80%). Regenerative medicine led the world stem cell market in terms of application. North America dominated the market for stem cells, and it is expected to keep this up through 2018. VistaGen Therapeutics, Terumo BCT, ZenBio, Saneron CCEL Therapeutics, Stem Cell Innovations, Opexa Therapeutics, Cellerant Therapeutics and Advanced Cell Technology are among the leading companies involved in the worldwide stem cell market.
The global stem cell market is poised to record a CAGR of just over 24% in the years ahead to surpass the USD 119.5 billion mark in 2018. The market growth is expected to be propelled by the advancements in neurological therapeutics supported by government financial aid, increasing prevalence of chronic conditions, rising importance of stem cell banking services, growing awareness relating to regenerative treatment options as well as the expansion of medical tourism, especially in China and India.
Topical research report “Stem Cell Markets” worked out by TriMark Publications (TriMark) examines the specific segments of the medical research market space using stem cells for R&D purposes.
The report presents a comprehensive overview of the stem cell market worldwide. It thoroughly reviews all of the generally accepted methods that are currently used for the preparation and use of stem cells. The study contains an extensive overview of stem cells’ use in the development of new therapies for various diseases as well as in drug discovery. The report also covers the important clinical trials as well as noteworthy events in the cell therapy sector, traces stem cell activity in different countries, provides vital information on commercial cell therapy products, and also profiles the leading companies involved in the stem cell market.
Stem Cell Markets
Published: August, 2013
Price: US$ 3,400.00
Other In-demand Market Research Reports by TriMark Include:
- Coagulation Diagnostic Testing Markets
- Regenerative Medicine Markets
- Therapeutic Drug Monitoring Markets
- New Oral Anticoagulants Markets
- Hemoglobin A1c Testing Markets
More topical and new market research reports by the publisher can be found at TriMark page.